天津药物研究院
天津药物研究院长;中国医学科学院药用植物开发研究所
1674-6384
12-1410/R
医药卫生科技
中药学
2009
5327次
季刊
天津市
Chinese Herbal Medicines期刊英文名字:中草药(英文版)
------/有基金-100.0%--https://mc03.manuscriptcentral.com/chm
期刊信息:本刊为:高质量科技期刊(T2), 科技核心(2024自然科学), CSCD核心(2025-2026), 知网收录, 目次收录(维普), 目次收录(万方),第一批认定学术期刊,外文期刊
《Chinese Herbal Medicines》期刊已被查看: 次
/有基金 100.0%
杂志社官网:http://www.tiprpress.com/chmen/home
联系电话:022-23006901(刊内;天津编辑部);010-57833035(官网;北京编辑部)
投稿邮箱:chm@tiprpress.com
主管单位:天津药物研究院
主办单位:天津药物研究院长;中国医学科学院药用植物开发研究所
地址:天津市滨海高新区惠仁道306号
邮编:
邮发:
欢迎广大学者朋友联系Chinese Herbal Medicines杂志社投稿订阅!
注意:本站并非《Chinese Herbal Medicines》杂志社官网,不提供征稿投稿服务,仅整理介绍该杂志内容!投稿请直接咨询杂志社!
1、投稿方式:在线投稿。
2、刊内网址:(202401期)
http://www.tiprpress.com
http://www.sciencedirect.com/journal/chinese-herbal-medicines
http://www.tiprpress.com/chmen/ch/index.aspx
http://www.elsevier.com/locate/chmed
https://mc03.manuscriptcentral.com/chm(投稿系统)
3、出刊日期:季刊,逢季首月18日出版。
2024年4月17日星期三
《中草药(英文版)》作者须知Instruction for Authors
【官网信息】
Chinese Herbal Medicines (CHM) is an official international journal sponsored by Tianjin Institute of Pharmaceutical Research and Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences. The purpose of CHM is to provide a forum for the studies on Chinese herbal medicines, phytomedicines, and natural products as well. The journal will accept the following contributions: letters, original articles, review papers, short communications, book reviews, conference announcements, information, etc. The journal involves the studies on active ingredients and complex formulations of herbal medicines in medicinal resource, phytochemistry, pharmacology, toxicology, pharmacokinetics, and therapeutic function by experiment and clinical trials. It is the interest of this journal to introduce the latest development in pharmaceutical sciences to readers.
The journal is included in the following databases: ESCI, PubMed Central, Scopus, DOAJ, CAB ABSTRACTS, CAS, EMBASE, IC, UPD, Global Health, etc. Since 2013, CHM has been selected as one of the Chinese Core Periodicals of Science and Technology for nine consecutive years. In 2019, CHM was successfully selected by China Association for Science and Technology for the China Science and Technology Journal Excellence Action Plan. The journal has been awarded the distinction of Excellent International Impact Academic Journals of China in 2016, 2019, 2020, 2021 and 2022.
1. Submission of manuscripts
Authors could submit their manuscripts through online submission http://mc03.manuscriptcentral.com/chm. The following should be complied with: size of character 12 point, double-spaced, consecutive numbering of the lines and pages. The text should be in Word document for Windows.
2. Structure of manuscripts
2.1 Title
Please provide a title that is concise, informative, and relevant, ideally it should contain no more than 30 words.
2.2 Authors and affiliation
Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Capitalize the first letter in the surname(s) and spell out the given name(s) in full-name form. The corresponding author should be indicated by an asterisk (*) to the right of the name and the e-mail address given in the footnote. The affiliation of each author should be provided, including complete address information (city, zip code, and country). Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address.
Any change in authorship must be approved in writing by all authors. Authors who have contributed equally should be marked with a superscript symbol (1). The following statement added in the footnote: “These authors contributed equally to this work”. The equal roles of authors should also be adequately disclosed in the authors’ contributions statement.
2.3 Abstract
The paper should contain an abstract with 200–300 words in English. The abstract should summarize the main points of the article. The structure form of the abstract should consist of Objective (purpose of the study), Methods (basic procedures), Results (final findings with main data), and Conclusion (potential possibility on the result).
……
更多详情:
https://www.tiprpress.com/chmen/site/menu/20100204181305001
Chinese Herbal Medicines杂志被以下数据库收录:
知网收录:CAS,WJCI
期刊荣誉:
该刊被以下数据库收录:CAS 化学文摘(美)(2025)WJCI 科技期刊世界影响力指数报告(2024)来源期刊
期刊荣誉:中国国际影响力优秀学术期刊;

主办中国科学院科技战略咨询研究院级别:北核,科核,CSCD扩,高T2,武B+
影响因子:2.672

主办湖南中医药大学;中华中医药学会级别:CSCD
影响因子:0.957

主办山东中医药学会、山东中医药大学级别:科核,CACJ-权威,武B+
影响因子:1.566

主办甘肃省中医药研究院;中华中医药学会级别:科核,武B+
影响因子:1.606

主办中华中医药学会、中国中医科学院级别:CSCD,高T1
影响因子:1.121

主办上海市针灸经络研究所级别:CSCD,科核
影响因子:0.538

主办上海中医药大学级别:CSCD,科核
影响因子:1.528

主办中国药理学会、中国科学院上海药物研究所级别:CSCD,科核
影响因子:2.098
杂志社官网:http://www.tiprpress.com/chmen/home
联系电话:022-23006901(刊内;天津编辑部);010-57833035(官网;北京编辑部)
投稿邮箱:chm@tiprpress.com
Chinese Herbal Medicines是核心期刊,级别是:科核,期刊类别是:分类下的知网,万方目次,维普目次收录的期刊。
我们不是《Chinese Herbal Medicines》杂志社。本站主要从事期刊信息展示与期刊推荐,不是任何杂志官网,直投稿件请联系杂志社。本站仅提供免费的学术指导、论文辅导、期刊投稿信息整理收集服务。
期刊发表的成功与否,主要取决于文章内容的质量。编辑老师会根据研究领域、创新性等多因素进行考量。优化投稿流程,避免频繁碰壁,缩短发表周期,节省您的宝贵时间,让您的学术成果快速发表
“专精特新”企业进行数字投资和专业投资,对中国打造数字竞争优势、发展新质生产力至关重要。本文基于2012—2023年1421家中国“专精特新”企业的面板数据,挖
实验利用紫外-可见吸收光谱研究了主客体掺杂型非线性聚合物薄膜(DR1/PMMA)的极化条件与生色团取向有序度、弛豫特性之间的关系。结果表明,在不改变其它条件的情
《房地产世界》26年中下左右版面,预计延迟2个月出刊刊期变动很快,发表请+V详询《房地产世界》是一本聚焦房地产与建筑相关领域的省级学术期刊,本刊主要报道房地产及
《汽车知识》26年上版面,预计次月出刊刊期变动很快,发表请+V详询《汽车知识》是一本聚焦汽车工程领域的国家级科技期刊,主要报道新能源、智能网联等汽车前沿技术,汽
💬暂时还没有点评哦~